Alzheimer's & Cognition
Daily News Podcast
Antibody cleared amyloid plaques, slowed cognitive decline
And claims that cannabis relieves noncancer pain go up in smoke.
Conference Coverage
Alzheimer’s trial design problem throws a wrench in promising BAN2401 results
CHICAGO – The trial arm with a statistically significant reduction in cognitive decline had fewer APOE4 carriers.
Conference Coverage
Mild cognitive impairment risk slashed by 19% in SPRINT MIND
Clinicians are calling blood pressure drugs the first disease-modifying therapy for MCI.
Evidence-Based Reviews
Neuropsychiatric symptoms of dementia: Monotherapy, or combination therapy?
A cholinesterase inhibitor plus memantine may be more effective than either medication alone.
Daily News Podcast
Blood pressure meds cut cognitive impairment risk
And HIV infection may double patients’ stroke rate.
Cases That Test Your Skills
Sudden-onset memory problems, visual hallucinations, and odd behaviors
Ms. D, age 62, is disoriented, distractible, tearful, and tangential. She reports that 'aerialists' are climbing through her windows at night and...
Conference Coverage
Monoclonal antibody slowed cognitive decline, cleared Alzheimer’s plaques in phase 2 trial
Savvy Psychopharmacology
Ruling out delirium: Therapeutic principles of withdrawing and changing medications
Ms. M, age 71, was diagnosed with Alzheimer’s disease several months ago and her clinical presentation and Mini-Mental Status Exam score of 22...
Conference Coverage
Pregnancy and years of reproductive capability linked to dementia risk
CHICAGO – The findings suggest that lifelong estrogen exposure may exert a neuroprotective effect in women.
Cases That Test Your Skills
Worsening agitation and hallucinations: Could it be PTSD?
Mr. G, age 57, presents with confusion, hallucinations, and agitation. He has a history of PTSD, depression, anxiety, and lung cancer. What could...
Feature
Gates Foundation, Lauder family launch $30 million Alzheimer’s biomarker search